Clinical Trials Logo
  1. Home
  2. Suicidal Behavior
  3. NCT04565834

Effect of Genetic Alterations in Key Genes in the Kynurenine Pathway on Suicidal Behavior — SuiKYN  

Suicidal Behavior Clinical Trial

Official title:
A Study on Genetic Alterations (Polymorphism) in Key Genes in the Kynurenine Pathway on Suicidal Behavior

Clinical Trial Summary

Current research has shown that an imbalance in the Kinurenine pathway plays a role in the physiopathology of neurogenerative and mental disorders (with a decrease in neuroprotective metabolites and an increase in neurotoxic products). So far the research has concentrated on the enzymes IDO, KAT, KMO, 3HAO and QPRT which are the key players in this pathway. Several polymorphisms affecting these enzymes have been associated with certain disorders characterized by a deregulation of the inflammation and immune response (McCauley et al 2009,Tardito et al 2013, Lee et al 2014), but no studies have ever tried to find a link between these enzymes and suicidal behavior. The investigators hypothesize that people who have attempted to commit suicide will have pro-inflammatory genetic variations affecting the kynurenine pathway.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04565834
Study type Observational
Source Centre Hospitalier Universitaire de Nimes
Contact Jorge LOPEZ-CASTROMAN, Professor
Phone +33466683897
Email Jorge.lopezcastroman@chu-nimes.fr
Status Recruiting
Phase
Start date December 1, 2019
Completion date September 1, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03185026 - Psychoeducation for Suicidal Behavior N/A
Recruiting NCT02824081 - Neuroinflammation, Serotonin, Impulsivity and Suicide N/A
Recruiting NCT05652153 - Inhibitory Mechanisms of Negative Urgency in Adolescent Suicidal Behavior N/A
Recruiting NCT02904005 - Predictors of Suicidal Behavior in Depression N/A
Suspended NCT04840134 - From Hardship to Hope: A Peer-led Intervention to Reduce Financial Hardship and Suicide Risk N/A
Completed NCT01118195 - Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans N/A
Completed NCT03080168 - The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety
Terminated NCT00449007 - Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism Phase 4
Recruiting NCT05409794 - Basal Plasma Lithium Levels and Suicidal Events
Terminated NCT02960191 - Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior N/A
Recruiting NCT05770388 - App-based Intervention to Promote Mental Health Help-seeking Among University Students N/A
Not yet recruiting NCT05417074 - Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide Phase 2
Recruiting NCT05656781 - Brief Intervention and Contact Program Main Trial N/A
Completed NCT03092271 - Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults N/A
Completed NCT03825354 - Brief Intervention and Contact (BIC) Program N/A